Hood River Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,216,040
| Closed | -$30.7M | – | 162 |
|
|
2025
Q1 | $30.7M | Buy |
9,216,040
+224,467
| +2% | +$747K | 0.52% | 75 |
|
|
2024
Q4 | $66.5M | Buy |
8,991,573
+846,936
| +10% | +$6.27M | 0.98% | 38 |
|
|
2024
Q3 | $76.5M | Buy |
8,144,637
+5,412,210
| +198% | +$50.8M | 1.23% | 29 |
|
|
2024
Q2 | $21.9M | Buy |
2,732,427
+108,189
| +4% | +$868K | 0.45% | 79 |
|
|
2024
Q1 | $38.9M | Buy |
2,624,238
+622,728
| +31% | +$9.23M | 0.87% | 45 |
|
|
2023
Q4 | $16.3M | Buy |
2,001,510
+9,175
| +0.5% | +$74.6K | 0.45% | 77 |
|
|
2023
Q3 | $9.07M | Buy |
1,992,335
+16,784
| +0.8% | +$76.4K | 0.29% | 84 |
|
|
2023
Q2 | $13.9M | Buy |
+1,975,551
| New | +$13.9M | 0.41% | 74 |
|
|
2021
Q2 | – | Sell |
-460,679
| Closed | -$14.6M | – | 121 |
|
|
2021
Q1 | $14.6M | Sell |
460,679
-44,732
| -9% | -$1.42M | 0.47% | 80 |
|
|
2020
Q4 | $23.5M | Buy |
505,411
+8,546
| +2% | +$397K | 0.78% | 57 |
|
|
2020
Q3 | $16.4M | Sell |
496,865
-50,447
| -9% | -$1.66M | 0.71% | 55 |
|
|
2020
Q2 | $15M | Buy |
+547,312
| New | +$15M | 0.67% | 60 |
|